Skip to main content
Top
Published in: Cancer Causes & Control 10/2014

Open Access 01-10-2014 | Editorial

The rhetoric of cancer

Author: Matthew Trendowski

Published in: Cancer Causes & Control | Issue 10/2014

Login to get access

Abstract

Background

Research involving the discovery of novel anticancer drugs and treatments hold precedence among the general public. However, investigating the etiology and epidemiology of malignancies can have a significant effect on reducing the prevalence of cancer in society. Understanding risk factors that drive neoplastic development can provide educated individuals the opportunity to avoid such catalysts.

Methods

Literature searches were conducted on prominent magazine and newspaper sources to analyze the accuracy and relevance the material had toward cancer prevention. Additionally, two professionals involved in oncology were interviewed to gain a more personal view of the population’s knowledge on cancer awareness and prevention.

Results

The lack of attention paid to the understanding of cancer and its subsequent prevention has resulted in fundamental misconceptions that facilitate the development of neoplastic growths.

Conclusions

Addressing the lack of attention paid to cancer awareness and prevention through proper education can have a significant effect on limiting the impact cancer has on society.
Literature
1.
go back to reference Weinberg RA (2013) The biology of cancer, 2nd edn. Garland science, New York Weinberg RA (2013) The biology of cancer, 2nd edn. Garland science, New York
2.
3.
go back to reference Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16(3):201–213PubMedCrossRef Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16(3):201–213PubMedCrossRef
4.
go back to reference Alberts B, Johnson A, Lewis J (2007) Molecular biology of the cell, 5th edn. Garland Science, New York, pp 890–894 Alberts B, Johnson A, Lewis J (2007) Molecular biology of the cell, 5th edn. Garland Science, New York, pp 890–894
5.
go back to reference Park A (2007) Top five cancer misconceptions. Time.com Park A (2007) Top five cancer misconceptions. Time.com
6.
go back to reference Proctor RN (2001) Tobacco and the global lung cancer epidemic. Nat Rev 1:82–87CrossRef Proctor RN (2001) Tobacco and the global lung cancer epidemic. Nat Rev 1:82–87CrossRef
8.
go back to reference Ellimoottil C, Polcari A, Kadlec A, Gupta G (2012) Readability of websites containing information about prostate cancer options. J Urol 188(6):2171–2176PubMedCrossRef Ellimoottil C, Polcari A, Kadlec A, Gupta G (2012) Readability of websites containing information about prostate cancer options. J Urol 188(6):2171–2176PubMedCrossRef
9.
10.
go back to reference Farina KL (2012) The economics of cancer care in the United States. Am J Manag Care 18:Web Farina KL (2012) The economics of cancer care in the United States. Am J Manag Care 18:Web
Metadata
Title
The rhetoric of cancer
Author
Matthew Trendowski
Publication date
01-10-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0428-9

Other articles of this Issue 10/2014

Cancer Causes & Control 10/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine